SYNthesis med chem Pty Limited’s US$80 Million Sale Of CRO Business

Michael Patrini

Ashurst has advised SYNthesis med chem Pty Limited on the deal. SYNthesis med chem Pty Limited, an Australian company, on sold its 100% equity interest in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here